Monocyte activation may attenuate with the diminishment of the post-AIS inflammation and the recovery of the disease (10), which is supported by the loss of association between plasma sCD163 concentrations and NIHSS at follow-up when neurological functions had been significantly improved. This evidence concerns the gene CD163 and androgen insensitivity syndrome.